Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072303 · ClinicalTrials.gov registry record
Pregnancy in Osteogenesis Imperfecta (OI) Registry
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 170
- Enrollment target
NCT03072303: Completed study, sponsored by University of South Florida.
NCT03072303 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03072303 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about pregnancy outcomes in osteogenesis imperfecta (OI). Patients enrolled in the Brittle Bone Disorders (BBD) Contact Registry (CR) will be invited via email to participate in this study.
Primary Outcome
The goal of this survey is to characterize the course and outcome of pregnancy in individuals with OI. This is a self-report survey that will review pregnancy outcomes (maternal and fetal). Measures of pregnancy outcome will include 1) length of gestation, 2) mode of delivery, 3) neonatal outcomes including birth weight and length, 4) history of back pain or hip pain and or fractures during pregnancy or postpartum 5) number of maternal hospital admissions 6) calcium and vitamin D intake, 7) neon
Interventions
- OTHER Web-based Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-06-16 |
| Est. Completion | 2019-09-13 |
What the finished NCT03072303 record still lists
NCT03072303 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Web-based Survey is the first listed.
NCT03072303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03072303 about?
NCT03072303 is a clinical study titled "Pregnancy in Osteogenesis Imperfecta (OI) Registry". The purpose of this study is to learn about pregnancy outcomes in osteogenesis imperfecta (OI). Patients enrolled in the Brittle Bone Disorders (BBD) Contact Registry (CR) will be invited via email to participate in this study.
What is the current status of trial NCT03072303?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2017-06-16. Estimated completion is 2019-09-13.
What interventions are being tested in trial NCT03072303?
The interventions under investigation include: Web-based Survey (OTHER).
Who is sponsoring clinical trial NCT03072303?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI